Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for The Joint Corp. (JYNT:NASDAQ), powered by AI.
The Joint Corp. is currently trading at $9.24. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for The Joint Corp. on Alpha Lenz.
The Joint Corp.'s P/E ratio is 48.1.
“The Joint Corp. trades at a P/E of 48.1 (premium valuation) with strong ROE of 16.3%.”
Ask for details →The Joint Corp. is a key player in the chiropractic care sector, focusing on providing accessible and affordable chiropractic services through its network of clinics. The company operates a franchise model, expanding its reach across various regions to deliver routine treatment without the need for insurance or appointments. Specializing in back, neck, and osteopathic health, The Joint Corp. caters to the growing demand for non-invasive, role-altering alternative to traditional medicine. A major feature of The Joint Corp. is its innovative approach to healthcare delivery, emphasizing convenience and customer-centricity in its service offerings. With a subscription-based model, the company supports consistent revenue streams while ensuring continuous care for its clients. Impacting the healthcare and wellness industries, The Joint Corp.'s presence underscores the increasing consumer inclination towards holistic and preventive health solutions. In the financial market, The Joint Corp. stands out by leveraging its unique position in a niche healthcare segment, contributing to its recognition as an emerging leader in chiropractic care. Its expanding footprint and consumer-friendly practices have made it a notable entity in the healthcare services market.
“The Joint Corp. trades at a P/E of 48.1 (premium valuation) with strong ROE of 16.3%.”
Ask for details →The Joint Corp. (ticker: JYNT) is a company listed on NASDAQ in the Healthcare sector (Medical Care Facilities). It has approximately 443 employees. Market cap is $140M.
The current price is $9.24 with a P/E ratio of 48.1x and P/B of 9.29x.
ROE is 16.28% and operating margin is -1.65%. Annual revenue is $55M.